Long-Term Care After a Transplant
All transplants take place in the BMT Inpatient Unit and the Day Hospital, where patients have access to a complete team of physicians and support staff that focus exclusively on blood and marrow transplants.
A bone marrow transplant is more like a transfusion, and no surgery is involved. Afterward, patients need strong support and careful monitoring. Because it takes time to develop a new immune system, patients are closely monitored for months or even years to prevent and treat complications. To better understand and navigate the BMT process, visit our transplant education page.
The BMT Program serves patients through a variety of dedicated areas.
- Outpatient Clinic — Patients visit the Outpatient Clinic for consultations, appointments and follow-up, including cancer rehabilitation and monitoring for graft vs. host disease.
- Day Hospital — In the Day Hospital, patients receive transplants and a high level of care during the day, and then return home at night.
- BMT Inpatient Unit — The BMT Inpatient Unit is for patients who need more intensive, 24-hour care in a highly supportive environment .
Graft vs. Host Disease ClinicAfter transplant, patients are carefully monitored for a variety of health complications. About 50 percent of patients who receive an allogeneic transplant develop a complication called graft vs. host disease (GVHD), in which the donor’s cells see the recipient’s body as foreign and attack it, causing damage.
Depending on the symptoms, GVHD can be acute, usually occurring within the first few months after transplant, or chronic, which can develop after an acute case and can last for months or years. Chronic GHVD is particularly challenging to manage because of its many different manifestations. Through our special GVHD Clinic, patients are closely monitored for symptoms and receive essential treatment if GVHD occurs.
In addition, Froedtert & The Medical College of Wisconsin form one of nine primary study sites of the Chronic GVHD Consortium, an integrated group of academic medical centers, patient support organizations and clinical research resources around the country dedicated to conducting clinical research in GVHD and improving the care and medical outcomes of patients who experience it. Our association with the consortium gives patients access to the latest clinical trials in the fight against GVHD.
Last Review Date: July 23, 2013
Online Editor(s): Shannon Krause